Compare ALB & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALB | WST |
|---|---|---|
| Founded | 1994 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 20.2B |
| IPO Year | 1994 | N/A |
| Metric | ALB | WST |
|---|---|---|
| Price | $162.81 | $260.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 7 |
| Target Price | $132.11 | ★ $338.00 |
| AVG Volume (30 Days) | ★ 3.1M | 666.9K |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.93% | 0.31% |
| EPS Growth | N/A | ★ 0.17 |
| EPS | N/A | ★ 6.75 |
| Revenue | ★ $4,946,415,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $6.97 |
| Revenue Next Year | $3.34 | $6.27 |
| P/E Ratio | ★ N/A | $41.39 |
| Revenue Growth | N/A | ★ 4.92 |
| 52 Week Low | $49.43 | $187.43 |
| 52 Week High | $179.14 | $348.90 |
| Indicator | ALB | WST |
|---|---|---|
| Relative Strength Index (RSI) | 61.32 | 37.75 |
| Support Level | $155.34 | $267.82 |
| Resistance Level | $179.14 | $281.55 |
| Average True Range (ATR) | 6.00 | 8.88 |
| MACD | 0.86 | -1.13 |
| Stochastic Oscillator | 58.58 | 1.84 |
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.